Charlotte Bronnimann

Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)

Matthias Preusser, Antonio Silvani, Émilie Le Rhun et al. · Neuro-Oncology · 2021 · 78 citations · Full text

Medicine, Neurological Surgery, Oncology +11

Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

L. Poetsch, Charlotte Bronnimann, Hugues Loiseau et al. · Journal of Neuro-Oncology · 2020 · 35 citations

Medicine, Genetics, Oncology +13

Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma

Salah Eddine Oussama Kacimi, Caroline Dehais, L. Feuvret et al. · Journal of Clinical Oncology · 2024 · 27 citations

Medicine, Oncology, Radiation Oncology +17

Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study

Antoine Seyve, Caroline Dehais, Olivier Chinot et al. · Neuro-Oncology · 2022 · 17 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort

Tuan Le Van, Thomas Graillon, Julian Jacob et al. · Journal of Neuro-Oncology · 2021 · 16 citations

Medicine, Oncology, Surgery +13